Kiara N. Berríos

Kiara N. Berríos

Auto-generated profile, based on publicly available information

Kiara N. Berríos

Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2025 in Science
Verified
Journal Article
Open access
IWIsaac P. Witte
Isaac P. Witte
GLGeorge D. Lampe
George D. Lampe
SESimon Eitzinger
Simon Eitzinger
SMShannon M. Miller
Shannon M. Miller
KBKiara N. Berríos
Kiara N. Berríos
DLDavid R. Liu
David R. Liu
Programmable gene integration in human cells has the potential to enable mutation-agnostic treatments for loss-of-function genetic diseases and facilitate many applications in the life sciences. CRISPR-associated transposases (CASTs) catalyze RNA-guided DNA integration but thus far demonstrate minimal activity in human cells. Using phage-assisted continuous evolution (PACE), we generated CAST variants with >200-fold average improved integration activity. The evolved CAST system (evoCAST) achieves ~10 to 30% integration efficiencies of kilobase-size DNA cargoes in human cells across 14 tested genomic target sites, including safe harbor loci, sites used for immunotherapy, and genes implicated in loss-of-function diseases, with undetected indels and low levels of off-target integration. Collectively, our findings establish a platform for the laboratory evolution of CASTs and advance a versatile system for programmable gene integration in living systems.

15 June 2023 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
TWTong Wang
Tong Wang
JFJohanna M. Fowler
Johanna M. Fowler
LLLaura Liu
Laura Liu
CLChristian E. Loo
Christian E. Loo
MLMeiqi Luo
Meiqi Luo
RKRahul M. Kohli
Rahul M. Kohli

18 October 2021 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
KBKiara N. Berríos
Kiara N. Berríos
NENiklaus H. Evitt
Niklaus H. Evitt
RDRachel A. DeWeerd
Rachel A. DeWeerd
DRDiqiu Ren
Diqiu Ren
MLMeiqi Luo
Meiqi Luo
RKRahul M. Kohli
Rahul M. Kohli

1 August 2018 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
JDJamie E DeNizio
Jamie E DeNizio
ESEmily K Schutsky
Emily K Schutsky
KBKiara N Berrios
Kiara N Berrios
MLMonica Yun Liu
Monica Yun Liu
RKRahul M. Kohli
Rahul M. Kohli

27 November 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAleksia Barka
Aleksia Barka
KBKiara N. Berríos
Kiara N. Berríos
PBPeter Bailer
Peter Bailer
ESEmily K. Schutsky
Emily K. Schutsky
TWTong Wang
Tong Wang
RKRahul M. Kohli
Rahul M. Kohli
Human APOBEC3A (A3A) is a nucleic acid-modifying enzyme that belongs to the cytidine deaminase family. Canonically, A3A catalyzes the deamination of cytosine into uracil in single-stranded DNA, an activity that makes A3A both a critical antiviral defense factor and a useful tool for targeted genome editing. However, off-target mutagenesis by A3A has been readily detected in both cellular DNA and RNA, which has been shown to promote oncogenesis. Given the importance of substrate discrimination for the physiological, pathological, and biotechnological activities of A3A, here we explore the mechanistic basis for its preferential targeting of DNA over RNA. Using a chimeric substrate containing a target ribocytidine within an otherwise DNA backbone, we demonstrate that a single hydroxyl at the sugar of the target base acts as a major selectivity determinant for deamination. To assess the contribution of bases neighboring the target cytosine, we show that overall RNA deamination is greatly reduced relative to that of DNA, but can be observed when ideal features are present, such as preferred sequence context and secondary structure. A strong dependence on idealized substrate features can also be observed with a mutant of A3A (eA3A, N57G) which has been employed for genome editing due to altered selectivity for DNA over RNA. Altogether, our work reveals a relationship between the overall decreased reactivity of A3A and increased substrate selectivity, and our results hold implications both for characterizing off-target mutagenesis and for engineering optimized DNA deaminases for base-editing technologies.